In this article
PT 141 is the research code for bremelanotide, a lab-made peptide that switches on melanocortin receptors in brain circuits tied to sexual desire. Regulators cleared the compound in June 2019 under a brand name, as a single-use autoinjector for one narrow group: premenopausal women with persistent, distressing low desire that nothing else explains. The “PT-141” vials sold online are a different thing.
- PT-141 acts centrally, mainly through MC4R, rather than on blood flow the way sildenafil or tadalafil do.
- The cleared indication covers premenopausal women with HSDD only. Men, postmenopausal women and performance enhancement are outside it.
- Roughly four in ten trial participants reported nausea, and blood pressure climbs briefly after each dose.
- Research protocols describe nasal use 30 to 60 minutes beforehand; the approved label cannot give a firm duration of effect.
What is PT 141 and how does it work?
The molecule descends from alpha-melanocyte-stimulating hormone and targets MC4R in particular. Because the effect starts in the brain, it is studied for desire itself, which is a different mechanism from drugs that widen blood vessels. It also explains the side-effect pattern: flushing and blood-pressure shifts, not visual disturbances.
Melanocortin receptors also govern pigment, so skin darkening appears among the cautions. The compound is a chemical relative of melanotan 2; both emerged from one research effort. A short summary sits on the Signal IQ PT-141 page.
PT 141 peptide for women
Women are the population the cleared product was tested in. Two matching Phase 3 studies (RECONNECT) randomised 1,267 premenopausal women with HSDD to bremelanotide or placebo, taken as needed across 24 weeks. Desire scores rose and desire-related distress fell more than with placebo, although the size of the benefit was modest.
The diagnosis requires that another cause, such as a medication, a relationship difficulty or a separate medical condition, does not account for the problem. Antidepressants, hormone shifts and depression are frequent contributors, so a clinical assessment precedes any treatment discussion. In research protocols on Signal IQ, women’s use is a single intranasal spray in one nostril, after sensitivity has been tested, taken when needed instead of on a schedule.
PT 141 peptide for men
Erectile dysfunction in men was investigated before the HSDD programme began, and some clinicians use the drug off-label. Still, the label does not list men, and the pivotal trials enrolled premenopausal women.
The protocol summarised on Signal IQ is one 100 mcg spray per nostril. Whether that is appropriate for any individual depends on cardiovascular history and blood pressure, which a clinician needs to review.
PT 141 nasal spray
Nasal delivery is how research protocols usually describe the compound. The cleared medicine, however, is an injector, so a nasal preparation is not the licensed form. Sprays sold online carry no verification of what they contain.
PT 141 dosage: ranges reported in research
| Group | Research protocol as reported | Timing |
|---|---|---|
| Men | One spray per nostril (100 mcg each), intranasal | 30 to 60 minutes ahead of activity |
| Women | One spray in a single nostril, intranasal, after a sensitivity test | On an as-needed basis, no fixed cycle |
How long does PT 141 take to work?
Research protocols place use between half an hour and an hour before the intended time. The licensed product’s label states that how long each dose lasts is not known and that the ideal timing window is not fully defined, so no single answer fits everyone.
PT 141 side effects
- Nausea: about 40% of trial participants had it. Of these, 13% required an anti-nausea drug and 8% discontinued. For most it eased by the second dose.
- Cardiovascular: after each dose, blood pressure rises briefly (peaks near 6 mmHg systolic and 3 mmHg diastolic) while heart rate dips, typically settling inside 12 hours.
- Skin darkening in patches: seen in roughly 1%, including on the face, gums and breasts. It occurs more with darker skin and more frequent use, and persisted in some people.
- Other effects: flushing, headache, vomiting and reactions where the drug is given. Nasal-use accounts also describe brief anxious feelings.
Approved bremelanotide versus online PT 141
| Factor | Approved product | Online “PT-141” |
|---|---|---|
| Regulatory review | Reviewed and cleared, with inspected manufacture | No review |
| What is inside | A set dose in a sealed injector | Powder whose identity and purity are unconfirmed |
| How it is obtained | Clinician prescription | Labelled “research use only” |
| Lawful for people | Yes, when prescribed | No |
Lab testing can show what a vial holds, yet that does not turn it into a medicine; see how to read a peptide CoA and research use vs human use. Related reading: peptides for women and peptide side effects.
Frequently asked questions
Is PT 141 FDA-approved?
Bremelanotide holds a single clearance, for HSDD in premenopausal women. PT-141 powder sold online is not that approved medicine.
How does PT 141 differ from sildenafil or tadalafil?
It works on melanocortin receptors in the brain instead of on blood vessels, so it acts on desire, not circulation.
What are the most common PT 141 side effects?
Nausea leads, followed by flushing, headache, vomiting and reactions at the dosing site, along with a short-lived blood-pressure rise.
Can men use PT 141?
The licensed product does not cover men. Any use is off-label and rests with a clinician who has checked cardiovascular risk.
Who should avoid PT 141?
People with uncontrolled hypertension or known cardiovascular disease, according to the label. A clinician does that screening.
References
- Kingsberg SA et al. Two randomized Phase 3 trials of bremelanotide in hypoactive sexual desire disorder (RECONNECT). Obstet Gynecol, 2019 — pubmed.ncbi.nlm.nih.gov
Go deeper on Signal IQ
Still have questions? Ask Pulse, Signal IQ’s free AI research assistant, or compare doses in the Peptide Dosage Chart.
Ask PulseEducational content only. Nothing here is medical advice or a recommendation to use any compound. Many peptides discussed are research compounds not approved for human use. Talk to a qualified clinician about your situation. Signal IQ does not sell peptides.



